Serum levels of sICAM-1 and 5-S-cysteinyldopa as markers of melanoma progression

Melanoma Research

Volumn 7, Issue 1, 1997, Pages 58-62

  Hirai, S ^a   Kageshita, T ^a   Kimura, T ^a   Tsujisaki, M ^a,b   Imai, K ^a,b   Wakamatsu, K ^a,c   Ito, S ^a,c   Ono, T ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Sapporo Medical University   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

5 S CD; melanoma; sICAM 1

Indexed keywords

CYSTEINYLDOPA; INTERCELLULAR ADHESION MOLECULE 1; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYSTEINYLDOPA; DISEASE PROGRESSION; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LONGITUDINAL STUDIES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; SOLUBILITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0031057263     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199702000-00009     Document Type: Article

References (24)

1. Merlin SD, Springer TA. Intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987; 15: 831-843.
2. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
3. Stauton DE, Dustin ML, Erickson HP et al. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 Cell 1990; 61: 243-254.
4. Kageshita T, Yoshii A, Kimura T, et al. Clinical relevance of 1CAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 1993; 53: 4927-4932.
5. Natali PG, Nicotra MR, Cavariere R, et al. Differential expression of intercellular adhesion molecule-1 in primary and metastatic melanoma lesions. Cancer Res 1990; 50: 1271-1278.
6. Johnson JP, Stade BG, Holtzman B, et al. De novo expression of intercellular adhesion molecule-1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989; 86: 641-644.
7. Altomonle M, Colizzi F, Esposito G, et al. Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 1993; 327: 959.
8. Rorsman H, Agrup G, Hansson C. et al. Biochemical recorders of malignant melanoma. In: MacKie RM (ed). Pigment Cell. Basel: Karger, 1983: 93-115.
9. Agrup G, Agrup P, Andersson T, et al. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis. Acta Dermatovener 1979; 59: 381-388.
10. Hu F, Woodward WR, Peterson LL. Plasma 5-S-cysteinyl dopa correlates with tumour size in melanoma-bearing mice, J Invest Dermatol 1988; 90: 149-151.
11. Peterson LL, Woodward WR, Fletcher WS, et al. Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects. J Am Acad Dermatol 1988; 19: 509-515.
12. Horikoshi T, Ito S, Wakamatsu K, et al. Evaluation of melanin-related metabolites as markers of melanoma progression. Cancer 1994; 73: 629-636.
13. Hara H, Walsh N, Yamada K et al. High plasma levels of a eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma, J Invest Dermatol 1994; 102: 501-505.
14. American Joint Committee on Cancer. Manual for Staging of Cancer. 3rd ed. Philadelphia: J. B. Lippincott, 1988. 139-144
15. Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991; 85: 3-8.
16. Rothlein R, Dustin ML, Marlin SD, et al. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986; 137: 1270-1274.
17. Matsui M, Temponi M, Ferrone S. Characterisation of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon. J Immunol 1987; 139; 2088-2095.
18. Temponi M, Kageshita T, Perosa T, et al. Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma 1989; 8: 85-95.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
20. Guesdon JL, Ternynck T, Avrameas S. The use of avidinbiotin interaction in immunoenzymatic techniques. J His-tochem Cytochem 1979; 27: 1131-1139.
21. Seth K, Raymond RD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338; 83-84.
22. Harning R, Mainolfi E, Hystryn JC et al. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 1991; 51; 5003-5005.
23. Adams DH, Mainolfi E, Elias E, et al. Detection of circulating intercellular adhesion molecule-1 after liver transplantation-evidence of local release within the liver during graft rejection Transplantation 1993; 55: 83-87.
24. Leeuwenberg JFM, Smeets EF, Neefjes JJ, et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. J Immunol 1992; 77: 543-549.